The Emory University Office of Technology Transfer holds its Seventh Annual Celebration of Technology and Innovation on Thursday, March 7, 2013 at the Emory Conference Center, Silver Bell Pavilion, 1615 Clifton Rd., NE, Atlanta, GA 30322.
The event begins with registration at 4:30 p.m., the program at 5:00 p.m., and a reception at 6:15 p.m.
Keynote speaker is Todd Sherer, PhD, Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research.
To RSVP: please contact Ashley Myers, 404-727-1785
Keynote speaker
Todd Sherer, PhD is Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research (MJFF). He directs the organization’s research strategy and is responsible for its overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson’s disease.
Sherer is one of the world’s foremost experts on the science and business of Parkinson’s drug development. He has played a major role in the Foundation’s efforts to increase the pharmaceutical industry’s investment in Parkinson’s disease drug development and engage the patient community to encourage and expand participation in clinical research.
Sherer’s work with the Foundation began in 2003, when, as a postdoctoral fellow at Emory School of Medicine, he was awarded MJFF funding to investigate the role of environmental factors in Parkinson’s disease. He joined the Foundation’s staff in April 2004 as Associate Director, Research Programs. He was promoted to Vice President in 2006, Chief Program Officer in 2010, and Chief Executive Officer in May 2011.
He is a member of the Board of Directors of the Parkinson’s Action Network and participates in the Institute of Medicine Forum on Neuroscience and Nervous System Disorders. He is a collaborating scientist for the Coalition Against Major Diseases and a member of the CINAPS Advisory Committee of the National Institute for Neurodegenerative Diseases and Stroke of the National Institutes of Health. He also serves on the National Center for Advancing Translational Sciences Council and the Cures Acceleration Network Review Board at the National Institutes of Health.
Emory University Office of Technology Transfer
Emory’s technology transfer program has one of the most robust product pipelines of any university in the country, with one of the nation’s leading programs for guiding technology developed in the laboratory through the patenting and licensing process to the marketplace and into the hands of consumers and patients.
Emory currently manages more than 1,100 active technologies invented by its scientists and physicians. This has led to the formation of more than 60 new companies and the introduction of more than 50 new products to market, some of which, like the discovery of several HIV drugs, have had major societal impact. Royalties earned from sales of new products by Emory licensees have resulted in more than $800 million that has subsidized additional Emory scientific research and education.
For more information: www.ott.emory.edu